Animal & Veterinary
-
FDA/CVM & NRSP-7 International Workshop Transcript - October 7, 2004
KEYNOTE: “---” denotes inaudible in the transcript.
“*” denotes word was phonetically spelled.
P R O C E E D I N G S
(8:35 a.m.)
-
Table of Contents
Welcome and Workshop Overview
Dr. Stephen Sundlof, FDA/CVMWelcome
Dr. Murray Lumpkin, FDAMUMS - US Situation
Dr. Andrew BeaulieuMUMS - EU Perspective
Dr. Peter JonesMUMS - Swiss Perspective
Dr. Flurina StuckiMUMS - African Perspective
Dr. Eric MitemaMUMS - Japanese Perspective
Dr. Tatsuro SekiyaMUMS - South American Perspective
Dr. Jorge ErrecaldeMUMS - Australian Perspective
Dr. Philip ReevesOffice of Rare Diseases at National Institutes of Health
Dr. Stephen GroftMUMS - Canadian Perspective
Dr. Elaine JettéMUMS - Industry Perspective - EU
Dr. Rick ClaytonMUMS - Industry Perspective - AHI
Dr. Richard CarnevaleOpen Public Comments I Forum Overview
Dr. Arthur CraigmillMUMS Forum I
Effectiveness and Target Animal SafetyMUMS Forum II
Environmental Safety Dr. Paul Bowser, ModeratorOpen Public Comments II
-
-
-







